Cargando…
Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485129/ https://www.ncbi.nlm.nih.gov/pubmed/31027499 http://dx.doi.org/10.1186/s13054-019-2434-5 |
| _version_ | 1783414221193609216 |
|---|---|
| author | Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, José A. Alós, Manuel Navarro, David |
| author_facet | Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, José A. Alós, Manuel Navarro, David |
| author_sort | Aguilar, Gerardo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6485129 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64851292019-05-03 Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, José A. Alós, Manuel Navarro, David Crit Care Letter BioMed Central 2019-04-26 /pmc/articles/PMC6485129/ /pubmed/31027499 http://dx.doi.org/10.1186/s13054-019-2434-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Aguilar, Gerardo Ferriols, Rafael Martínez-Castro, Sara Ezquer, Carlos Pastor, Ernesto Carbonell, José A. Alós, Manuel Navarro, David Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| title | Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| title_full | Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| title_fullStr | Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| title_full_unstemmed | Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| title_short | Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| title_sort | optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485129/ https://www.ncbi.nlm.nih.gov/pubmed/31027499 http://dx.doi.org/10.1186/s13054-019-2434-5 |
| work_keys_str_mv | AT aguilargerardo optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT ferriolsrafael optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT martinezcastrosara optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT ezquercarlos optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT pastorernesto optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT carbonelljosea optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT alosmanuel optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration AT navarrodavid optimizingceftolozanetazobactamdosageincriticallyillpatientsduringcontinuousvenovenoushemodiafiltration |